BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tsukioka T, Izumi N, Mizuguchi S, Kyukwang C, Komatsu H, Toda M, Hara K, Miyamoto H, Nishiyama N. Positive correlation between sarcopenia and elevation of neutrophil/lymphocyte ration in pathological stage IIIA (N2-positive) non-small cell lung cancer patients. Gen Thorac Cardiovasc Surg 2018;66:716-22. [DOI: 10.1007/s11748-018-0985-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Detopoulou P, Voulgaridou G, Papadopoulou S. Cancer, Phase Angle and Sarcopenia: The Role of Diet in Connection with Lung Cancer Prognosis. Lung 2022. [PMID: 35616720 DOI: 10.1007/s00408-022-00536-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Gholizade M, Farhadi A, Marzban M, Mahmudpour M, Nabipour I, Kalantarhormozi M, Shafiee G, Ostovar A, Larijani B, Darabi AH, Safavi E. Association between platelet, white blood cell count, platelet to white blood cell ratio and sarcopenia in community-dwelling older adults: focus on Bushehr Elderly Health (BEH) program. BMC Geriatr 2022;22:300. [PMID: 35395731 DOI: 10.1186/s12877-022-02954-3] [Reference Citation Analysis]
3 Chang B, Peng T, Wu Y, Hsieh T, Huang C. Prognostic Values of Inflammatory Indexes and Clinical Factors in Patients with Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma and Treated with Tyrosine Kinase Inhibitors. JPM 2022;12:404. [DOI: 10.3390/jpm12030404] [Reference Citation Analysis]
4 Kawaguchi Y, Hanaoka J, Ohshio Y, Okamoto K, Kaku R, Hayashi K, Shiratori T, Akazawa A. Sarcopenia increases the risk of post-operative recurrence in patients with non-small cell lung cancer. PLoS One 2021;16:e0257594. [PMID: 34551011 DOI: 10.1371/journal.pone.0257594] [Reference Citation Analysis]
5 Kawaguchi Y, Hanaoka J, Ohshio Y, Okamoto K, Kaku R, Hayashi K, Shiratori T, Akazawa A. Does sarcopenia affect postoperative short- and long-term outcomes in patients with lung cancer?-a systematic review and meta-analysis. J Thorac Dis 2021;13:1358-69. [PMID: 33841929 DOI: 10.21037/jtd-20-3072] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
6 Marhold M, Topakian T, Unseld M. Sarcopenia in cancer—a focus on elderly cancer patients. memo 2021;14:20-3. [DOI: 10.1007/s12254-020-00637-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
7 Looijaard SMLM, Te Lintel Hekkert ML, Wüst RCI, Otten RHJ, Meskers CGM, Maier AB. Pathophysiological mechanisms explaining poor clinical outcome of older cancer patients with low skeletal muscle mass. Acta Physiol (Oxf) 2021;231:e13516. [PMID: 32478975 DOI: 10.1111/apha.13516] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
8 Nishimura JM, Ansari AZ, D’souza DM, Moffatt-bruce SD, Merritt RE, Kneuertz PJ. Computed Tomography-Assessed Skeletal Muscle Mass as a Predictor of Outcomes in Lung Cancer Surgery. The Annals of Thoracic Surgery 2019;108:1555-64. [DOI: 10.1016/j.athoracsur.2019.04.090] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
9 Deng H, Zha P, Hou L, Huang K. Does sarcopenia have any impact on survival of patients with surgically treated non-small-cell lung cancer? Interactive CardioVascular and Thoracic Surgery 2019;29:144-7. [DOI: 10.1093/icvts/ivz039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]